CooperCompanies' Q4 revenue beats estimates

The Cooper Companies

04/12/2025 21:29

Overview

CooperCompanies fiscal Q4 revenue rises 5%, beating analyst expectations

Adjusted EPS for fiscal Q4 beats consensus, up 11%

Company repurchased $197.3 mln of common stock in Q4

Outlook

CooperCompanies expects fiscal 2026 revenue of $4.299 bln to $4.338 bln

Company anticipates fiscal 2026 adj EPS of $4.45 to $4.60

CooperCompanies projects fiscal 2026 free cash flow of $575 mln to $625 mln

Result Drivers

REORGANIZATION IMPACT - Co's Q4 results benefited from reorganization activities improving operational efficiency and reducing costs

PRODUCT MOMENTUM - CooperVision's growth driven by MyDay contract wins and MiSight's strong Q4 performance

FERTILITY BUSINESS - CooperSurgical's strong Q4 revenue supported by robust fertility business

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Slight Beat*
$1.07 bln
$1.06 bln (15 Analysts)
Q4 Adjusted EPS
Beat
$1.15
$1.11 (16 Analysts)
Q4 EPS
$0.43
Q4 Gross Margin
61%
Q4 EBIT Margin
13%


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Cooper Companies Inc is $85.00, about 11.9% above its December 3 closing price of $75.98

The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release: ID:nGNX3p38XJ

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)